Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma

Clinical trial NCT06339424 · RECRUITING

Trial details

NCT number: NCT06339424
Sponsor: Chang Gung Memorial Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-03-30
Primary completion: 2029-03-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.